In the study from Seki et al., the authors illustrated that TGF-β signaling in hepatocytes drives fibrogenesis, inflammation, and subsequently HCC development in mice with hepatocyte-specific Tak1 deficiency. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.